Alerus Financial Na Edwards Lifesciences Corp Transaction History

Alerus Financial Na

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$86.5 - $128.27 $1.53 Million - $2.27 Million	-17,720 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$101.96 - $128.34 $1.24 Million - $1.57 Million	-12,202 Reduced 40.78%	17,720 $2.09 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $121,049 - $148,713	1,138 Added 3.95%	29,922 $3.88 Million
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $2,366 - $2,823	-23 Reduced 0.08%	28,784 $3.26 Million
Q2 2021 Aug 11, 2021	SELL	$83.84 - $104.76 $963,992 - $1.2 Million	-11,498 Reduced 28.53%	28,807 $2.98 Million
Q1 2021 May 13, 2021	BUY	$78.68 - $90.67 $696,475 - $802,610	8,852 Added 28.14%	40,305 $3.37 Million
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $1.2 Million - $1.52 Million	16,706 Added 113.28%	31,453 $2.87 Million
Q3 2020 Nov 13, 2020	BUY	$67.19 - $87.44 $370,620 - $482,319	5,516 Added 59.76%	14,747 $1.18 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $531,151 - $710,325	9,231 New	9,231 $638,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Alerus Financial Na, based on Form 13F filings with the SEC.

Stay updated on Alerus Financial Na with notifications on news.